Bio & Health Tech
Divergent Paths: China, EU, and US Approaches to Neurotechnology Regulation
Major global powers like China, the EU, and the US are adopting distinct regulatory and ethical frameworks for advancing neurotechnology, particularly Brain-Computer Interfaces (BCIs). Understanding these divergent paths is crucial for navigating global governance challenges and strategic decisions in this rapidly evolving field.
David Yazzie·October 1, 2026